Gujarat High Court Strikes Down Section 148 Reopening in Lambda Therapeutic Case: Change of Opinion Cannot Justify Reassessment
Overview
The Gujarat High Court, in its judgment dated 19 September 2022 in Lambda Therapeutic Research Limited Vs DCIT (R/Special Civil Application No. 17583 of 2021), delivered a significant ruling reinforcing the boundaries of the Assessing Officer's powers under Section 147 and Section 148 of the Income Tax Act, 1961. The Court held that where a scrutiny assessment has already been completed after due examination of relevant facts, the Assessing Officer cannot invoke reassessment proceedings merely to take a fresh look at the same material. Such an exercise amounts to nothing more than a change of opinion and is legally impermissible.
Background of the Case
The Assessee and Its Investment Profile
Lambda Therapeutic Research Limited is engaged in the business of providing clinical research services. For Assessment Year 2014–15, the assessee's non-current investments, as reflected in its annual accounts, aggregated to Rs. 59,11,96,725/- as on 31.03.2013 and Rs. 69,58,82,489/- as on 31.03.2014. A substantial portion of these investments were held in the shares of foreign companies, and dividends received from foreign company shares were taxable in the hands of the assessee. The assessee had also incurred interest expenditure of Rs. 3,19,34,823/- as disclosed in its profit and loss account.
Suo Motu Disallowance Under Section 14A
While filing its return of income on 27 November 2014, the assessee voluntarily made a disallowance of Rs. 1,12,869/- under Section 14A of the Income Tax Act, 1961. This self-computed disallowance was arrived at by applying 0.5% of the average value of investments earning exempt income, as per Rule 8D(2)(iii) of the Income Tax Rules, in the absence of specific interest-bearing borrowings attributable to such investments.
Original Scrutiny Assessment Proceedings
Notice and Information Submitted
The case was selected for scrutiny, and a notice was issued on 2 August 2017 under Section 142(1) of the Income Tax Act, 1961. The Assessing Officer specifically called for details relating to interest-free and interest-bearing loans and advances, shareholding patterns, and working of the disallowance under Section 14A. The assessee responded by letter dated 30 August 2017, furnishing:
- A detailed computation of the
Section 14Adisallowance amounting to Rs. 1,12,869/- - Details of loans and advances extended to foreign entities such as Jina Pharmaceuticals Inc. and Lambda Therapeutic Ltd. UK
- Complete shareholding pattern of the company
The disallowance computation submitted by the assessee was worked out as follows:
| Particulars | Amount (INR) |
|---|---|
| Opening balance of Investment earning Exempt Income | Rs. 1,000/- |
| Closing balance of Investment earning Exempt Income | Rs. 4,51,46,499/- |
| Average of Investment Balances | Rs. 2,25,73,750/- |
| Disallowance @ 0.5% of Average Balances | Rs. 1,12,869/- |
Assessment Order Passed
After considering the submissions, the Assessing Officer passed an order dated 25 January 2018 under Section 143(3) read with Section 144C of the Income Tax Act, 1961. On the issue of Section 14A, the Assessing Officer computed a total disallowable amount of Rs. 32,17,698/- under Rule 8D(2)(iii), representing 0.5% of the average investment of Rs. 64,35,39,607/- as appearing in the financial statements. Since the assessee had already made a suo motu disallowance of Rs. 1,12,869/-, the net additional disallowance worked out to Rs. 31,04,829/- (i.e., Rs. 32,17,698/- minus Rs. 1,12,869/-).